Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Poland

Lilly Suspends Shipment Of Schizophrenia Drug To Poland

July 2006 | Company News Alert

US firm Eli Lilly has suspended importation of its schizophrenia drug Zyprexa (olanzapine) because the Polish Ministry of Health imposed an unacceptably low price for the product on the recently amended reimbursement

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>